RMD Earnings
Latest Revenue1.5B
Latest Net Income383.4M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q4 2026 | $2.65 | 1.5B | 383.4M | +8.6% | +2.3% |
| Q3 2026 | $2.74 | 1.4B | 398.7M | +10.8% | +10.0% |
| Q2 2026 | $2.69 | 1.4B | 392.6M | +11.0% | +14.5% |
| Q1 2026 | $2.38 | 1.3B | 348.5M | +9.1% | +12.3% |
| Q4 2025 | $2.59 | 1.3B | 379.7M | +10.2% | +30.2% |
| Q3 2025 | $2.49 | 1.3B | 365.0M | +7.9% | +22.1% |
| Q2 2025 | $2.35 | 1.3B | 344.6M | +10.3% | +65.5% |
| Q1 2025 | $2.12 | 1.2B | 311.4M | +11.1% | +42.3% |
| Q4 2024 | $1.99 | 1.2B | 292.2M | — | — |
| Q3 2024 | $2.04 | 1.2B | 300.5M | — | — |
| Q2 2024 | $1.42 | 1.2B | 208.8M | — | — |
| Q1 2024 | $1.49 | 1.1B | 219.4M | — | — |
ResMed (RMD) — Earnings